You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IV melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participation Patterns Among Stage IV Melanoma Patients

Not yet recruiting
  • Stage IV Melanoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Anxiety, Stage IV Melanoma Trial in Miami Beach (psilocybin)

    Withdrawn
    • Anxiety
    • Stage IV Melanoma
    • Miami Beach, Florida
      Mount Sinai Comprehensive Cancer Center
    Jun 13, 2022

    Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

    Not yet recruiting
    • Melanoma
    • ABP 206
    • +2 more
    • (no location specified)
    Jun 8, 2023

    Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 6, 2022

    Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

    Completed
    Has Results
    • Melanoma
    • Skin Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 18, 2023

    Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

    Not yet recruiting
    • Melanoma
    • Unresectable Melanoma
    • Los Angeles, California
    • +3 more
    Aug 4, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Sep 17, 2022

    Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

    Not yet recruiting
    • Melanoma
    • Urothelial Carcinoma
    • Berlin, Germany
      Local Institution - 0001
    Aug 9, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 28, 2022

    Melanoma Trial in Providence (Ipilumumab, Nivolumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • Providence, Rhode Island
      Rhode Island Hospital and The Miriam Hospital
    Feb 24, 2022

    Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)

    Active, not recruiting
    • Metastatic Melanoma
    • Boston, Massachusetts
    • +1 more
    Mar 22, 2022

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)

    Recruiting
    • Stage III Melanoma
    • Stage IV Melanoma
    • TBX-3400
    • Los Angeles, California
    • +1 more
    May 1, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 17, 2023

    Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

    Recruiting
    • Melanoma
    • Los Angeles, California
    • +3 more
    Mar 29, 2022

    Metastatic Melanoma Trial in Louisville (Ipilimumab, GM-CSF)

    Completed
    Has Results
    • Metastatic Melanoma
    • Louisville, Kentucky
      James Graham Brown Cancer Center
    Oct 22, 2021

    Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)

    Recruiting
    • Advanced Melanoma
    • JS001+Imatinib mesylate
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Mar 2, 2022

    Metastatic Melanoma Trial in Louisville (Ipilimumab)

    Terminated
    Has Results
    • Metastatic Melanoma
    • Louisville, Kentucky
      James Graham Brown Cancer Center
    Oct 22, 2021

    Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • Sargramostim (GM-CSF)
    • Pembrolizumab (anti-PD-1)
    • Boston, Massachusetts
    • +1 more
    Jul 6, 2022

    Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

    Completed
    • Stage III Malignant Melanoma of Skin AJCC V6
    • Stage IV Malignant Melanoma of Skin
    • TAPCells vaccine
    • Santiago, RM, Chile
      Faculty of Medicine, University of Chile
    Nov 21, 2023

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

    Active, not recruiting
    • Metastatic Melanoma
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 13, 2023

    Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

    Active, not recruiting
    • Metastatic Melanoma
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jan 3, 2023

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Melanoma Trial in New York (DS-8273a, Nivolumab)

    Completed
    • Melanoma
    • DS-8273a
    • Nivolumab
    • New York, New York
      Laura and Isaac Perlmutter Cancer Center
    Oct 8, 2021

    Melanoma, Cancer Trial in Cambridge (Encorafenib + Binimetinib, Standard Adjuvant Treatment)

    Not yet recruiting
    • Melanoma
    • Cancer
    • Encorafenib + Binimetinib
    • Standard Adjuvant Treatment
    • Cambridge, England, United Kingdom
      Addenbrooke's Hospital
    Oct 15, 2021